Show simple item record

dc.contributor.authorBle, Aen
dc.contributor.authorMasoli, JAHen
dc.contributor.authorBarry, HEen
dc.contributor.authorWinder, REen
dc.contributor.authorTavakoly, Ben
dc.contributor.authorHenley, WEen
dc.contributor.authorKuchel, GAen
dc.contributor.authorValderas, JMen
dc.contributor.authorMelzer, Den
dc.contributor.authorRichards, SHen
dc.date.accessioned2017-05-10T10:11:42Z
dc.date.available2017-05-10T10:11:42Z
dc.date.issued2015-11-05en
dc.identifier.urihttp://hdl.handle.net/10026.1/9213
dc.description.abstract

BACKGROUND: High risk medications are commonly prescribed to older US patients. Currently, less is known about high risk medication prescribing in other Western Countries, including the UK. We measured trends and correlates of high risk medication prescribing in a subset of the older UK population (community/institutionalized) to inform harm minimization efforts. METHODS: Three cross-sectional samples from primary care electronic clinical records (UK Clinical Practice Research Datalink, CPRD) in fiscal years 2003/04, 2007/08 and 2011/12 were taken. This yielded a sample of 13,900 people aged 65 years or over from 504 UK general practices. High risk medications were defined by 2012 Beers Criteria adapted for the UK. Using descriptive statistical methods and regression modelling, prevalence of 'any' (drugs prescribed at least once per year) and 'long-term' (drugs prescribed all quarters of year) high risk medication prescribing and correlates were determined. RESULTS: While polypharmacy rates have risen sharply, high risk medication prevalence has remained stable across a decade. A third of older (65+) people are exposed to high risk medications, but only half of the total prevalence was long-term (any = 38.4 % [95 % CI: 36.3, 40.5]; long-term = 17.4 % [15.9, 19.9] in 2011/12). Long-term but not any high risk medication exposure was associated with older ages (85 years or over). Women and people with higher polypharmacy burden were at greater risk of exposure; lower socio-economic status was not associated. Ten drugs/drug classes accounted for most of high risk medication prescribing in 2011/12. CONCLUSIONS: High risk medication prescribing has not increased over time against a background of increasing polypharmacy in the UK. Half of patients receiving high risk medications do so for less than a year. Reducing or optimising the use of a limited number of drugs could dramatically reduce high risk medications in older people. Further research is needed to investigate why the oldest old and women are at greater risk. Interventions to reduce high risk medications may need to target shorter and long-term use separately.

en
dc.format.extent146 - ?en
dc.languageengen
dc.language.isoengen
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectCross-Sectional Studiesen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectInappropriate Prescribingen
dc.subjectMaleen
dc.subjectMedical Records, Problem-Orienteden
dc.subjectPolypharmacyen
dc.subjectPotentially Inappropriate Medication Listen
dc.subjectPractice Patterns, Physicians'en
dc.subjectPrevalenceen
dc.subjectPrimary Health Careen
dc.subjectRisk Assessmenten
dc.subjectRisk Factorsen
dc.subjectTimeen
dc.subjectUnited Kingdomen
dc.titleAny versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12.en
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/26542116en
plymouth.volume15en
plymouth.publication-statusPublished onlineen
plymouth.journalBMC Geriatren
dc.identifier.doi10.1186/s12877-015-0143-8en
plymouth.organisational-group/Plymouth
dc.publisher.placeEnglanden
dcterms.dateAccepted2015-10-30en
dc.identifier.eissn1471-2318en
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.1186/s12877-015-0143-8en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2015-11-05en
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV